Atlas Trials

Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia

Clinical trial NCT00047502 · COMPLETED

Trial details

NCT number
NCT00047502
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Myelogenous Leukemia
Start date
2002-11-01
Primary completion
2006-04-10
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.